Research by Therapeutic Area (A-G)
Presented at PHPN 2025
Research showing how patient-reported outcomes can help specialty pharmacy clinicians track disease impact and support treatment decisions between provider visits.
Presented at PHA 2024
This study highlights how specialty pharmacy clinicians support successful transitions from branded epoprostenol therapies through prescriber collaboration, patient counseling, and specialized nurse training, helping prevent gaps in care.
Presented at PHPN 2023
This study evaluated patient experiences with treprostinil dry powder inhalers and the role of specialty-trained PAH nurses in supporting successful therapy transitions without interruptions in care.
Presented at ATS 2022
This study found that specialty pharmacy-prepared prostacyclin cassettes improved convenience and were associated with lower infection and adverse event rates compared to patient-mixed therapy.
Presented at PHPN 2021
This study explores the impact of Accredo's WellBeing Watch™ program on supporting the unique needs of patients with pulmonary arterial hypertension.
The Adherence Impact of Multi-Modal Clinical Engagement
Presented at AMCP 2025
This study explores how telehealth coaching and digital support tools can improve medication adherence for specialty patients.
Presented at NBDF 2025
This case study highlights how optimized emicizumab-kxwh dosing can reduce injection burden, eliminate drug waste, and improve the patient experience while lowering healthcare costs.
Presented at NHF 2023
This study explores how pharmacist and prescriber collaboration can optimize factor IX dosing, helping reduce infusion burden while supporting positive clinical and cost outcomes.
Mitigating Refill Gaps in CF
Presented at NACFC 2019
This study evaluated how proactive specialty pharmacy outreach can improve medication adherence and help reduce gaps in care for people with cystic fibrosis.
Presented at AMCP 2024
This study examines how safety labeling changes can influence utilization and treatment persistence for osteoporosis therapies, providing insights for patient care and specialty management.
Presented at NORD Rare Summit 2023
This study examines how a drug recall affected treatment access and medication use for patients with severe hypoparathyroidism, highlighting the impact of care disruptions in rare disease populations.
Motivational Interviewing and Specialty Adherence Improvement
Presented at AMCP 2024
This study examines how telehealth-based motivational interviewing can help improve medication adherence for specialty patients across diverse therapeutic areas.
Research by Therapeutic Area (H-Z)
Real-World Adherence Patterns and Characteristics of Patients Initiating Injectable Cabotegravir for PrEP or HIV Treatment
Presented at IDWeek 2025
This study examines adherence patterns among patients using long-acting injectable cabotegravir for HIV treatment and PrEP, highlighting opportunities for clinical support to improve therapy management.
Presented at AAAAI 2024
This study highlights how specialty pharmacists can help identify appropriate patients for optimized dosing schedules, improving quality of life while reducing healthcare costs.
Presented at AAAAI 2019
This study found that an evidence-based specialty pharmacy care program helped reduce the frequency and severity of adverse reactions associated with home IVIG infusions.
Presented at CMSC 2026
This retrospective review found that home infusion for people with MS can provide a safe treatment option with comparable visit times and reduced travel compared to traditional care settings.
Presented at CMSC 2020
This study examines treatment trends, healthcare utilization, and infection rates in people with multiple sclerosis, highlighting the value of specialty pharmacy support in disease management.
Access to Dietitian at Specialty Pharmacy Addresses Gaps in Nutrition Care
Presented at Oncology Nursing Congress 2025
This study highlights how access to a registered dietitian through specialty pharmacy can help address nutrition care gaps for oncology patients.
Presented at AMCP 2026
This study examines adoption, discontinuation, and switching patterns among patients using adalimumab biosimilars, highlighting opportunities to improve access and reduce treatment costs.
Presented at ISPOR 2024
This research explores how specialty pharmacy services can support patients with inflammatory conditions while helping improve healthcare resource utilization and reduce overall medical costs.
Presented at AIBD 2022
Research showing that infliximab home infusion can provide a safe and convenient treatment option for patients with inflammatory conditions.
Presented at AMCP 2020
Research examining how adherence to biologic treatments may impact pain management and opioid utilization in patients with inflammatory conditions.